Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Trial to Assess Consumer Self-Selection and Use of Gabapentin for Occasional Sleeplessness in an Over-the-Counter Environment

ClinicalTrials.gov ID: NCT00659100

Public ClinicalTrials.gov record NCT00659100. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 5:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 3-Month, Open-Label, Pharmacy-Based, Actual-Use Trial in a Simulated Over-The-Counter (OTC) Environment to Assess Self-Selection and Consumer Use Patterns of Gabapentin 250 mg for Occasional Sleeplessness

Study identification

NCT ID
NCT00659100
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Industry
Enrollment
1,254 participants

Conditions and interventions

Interventions

  • Gabapentin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2006
Primary completion
Not listed
Completion
Dec 31, 2006
Last update posted
Feb 1, 2021

2006 – 2007

United States locations

U.S. sites
35
U.S. states
11
U.S. cities
32
Facility City State ZIP Site status
Pfizer Investigational Site Anaheim California 92801
Pfizer Investigational Site Bonita California 91902
Pfizer Investigational Site Fallbrook California 92028
Pfizer Investigational Site Hacienda Heights California 91746
Pfizer Investigational Site La Mesa California 91942
Pfizer Investigational Site Oceanside California 92054
Pfizer Investigational Site Orange California 92866
Pfizer Investigational Site San Dimas California 91773
Pfizer Investigational Site Pembroke Pines Florida 33026
Pfizer Investigational Site Weston Florida 33326
Pfizer Investigational Site Baltimore Maryland 21228
Pfizer Investigational Site Elk River Minnesota 55330
Pfizer Investigational Site Northfield Minnesota 55057
Pfizer Investigational Site Red Wing Minnesota 55066
Pfizer Investigational Site Saint Louis Park Minnesota 55426
Pfizer Investigational Site Holly Springs Mississippi 38625
Pfizer Investigational Site Belton Missouri 64012
Pfizer Investigational Site Independence Missouri 64054
Pfizer Investigational Site Albuquerque New Mexico 87104
Pfizer Investigational Site Albuquerque New Mexico 87110
Pfizer Investigational Site Taos New Mexico 87571
Pfizer Investigational Site Cary North Carolina 27513
Pfizer Investigational Site Chapel Hill North Carolina 27514
Pfizer Investigational Site Raleigh North Carolina 27606
Pfizer Investigational Site Raleigh North Carolina 27609
Pfizer Investigational Site Raleigh North Carolina 27612
Pfizer Investigational Site Houston Texas 77088
Pfizer Investigational Site Pearland Texas 77581
Pfizer Investigational Site Bountiful Utah 84010
Pfizer Investigational Site Ogden Utah 84401
Pfizer Investigational Site Salt Lake City Utah 84121
Pfizer Investigational Site Syracuse Utah 84075
Pfizer Investigational Site West Valley City Utah 84120
Pfizer Investigational Site Falls Church Virginia 22041
Pfizer Investigational Site Richmond Virginia 23233

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00659100, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 1, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00659100 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →